Health Reforms in Germany Will Squeeze Parallel Trade Sector and Wholesalers
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharmaceutical pricing fallout from Germany's health reforms will be felt beyond the branded pharmaceutical firms. Also hit are the country's wholesalers and parallel traders.